Gradalis® is leading a new way to fight cancer

Find out how

Gradalis is developing Vigil®, a fully personalized, patient-specific cancer immunotherapy with potential applications across multiple solid tumor types including ovarian cancer.

Vigil is currently for people with

See how we can help

Contact us